Fund Holdings — Tri Locum Partners LP

Total Portfolio Value:
$417.41M
Total Bought:
$182.54M
Total Sold:
$162.04M
Net Transaction:
+$20.50M
Notable People:
Tri Locum Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Pfizer Inc.(PFE)596,9191,732,935+1,136,016$16.70M$50.15M12.01%+$33.45M
Teva Pharmaceutical Industries LimitedADS(TEVA)2,550,3072,755,737+205,430$41.44M$49.66M11.90%+$8.22M
Natera, Inc.(NTRA)230,585317,439+86,854$24.97M$40.30M9.65%+$15.33M
Stevanato Group S P A
ORD SHS
565,4221,867,938+1,302,516$10.37M$37.36M8.95%+$26.99M
argenx SEADR(ARGX)74,55862,474-12,084$32.06M$33.87M8.11%+$1.80M
Inspire Medical Systems, Inc.(INSP)133,276151,429+18,153$17.84M$31.96M7.66%+$14.12M
Vaxcyte, Inc.(PCVX)113,344271,922+158,578$8.56M$31.07M7.44%+$22.51M
Avadel Pharmaceuticals Plc01,660,955+1,660,955$0$21.78M5.22%+$21.78M
United Therapeutics Corporation(UTHR)50,10054,926+4,826$15.96M$19.68M4.72%+$3.72M
Legend Biotech CorporationADS(LEGN)356,532362,270+5,738$15.79M$17.65M4.23%+$1.86M
Verona Pharma PlcADS0593,980+593,980$0$17.09M4.09%+$17.09M
Insmed Incorporated(INSM)316,501143,920-172,581$21.21M$10.51M2.52%-$10.70M
Biohaven Ltd.(BHVN)0193,195+193,195$0$9.65M2.31%+$9.65M
Merus N V335,514192,157-143,357$19.85M$9.60M2.30%-$10.25M
Mind Medicine Mindmed Inc382,0551,662,953+1,280,898$2.75M$9.46M2.27%+$6.71M
Madrigal Pharmaceuticals, Inc.(MDGL)65,35243,287-22,065$18.31M$9.19M2.20%-$9.12M
Axsome Therapeutics, Inc.(AXSM)306,51391,721-214,792$24.67M$8.24M1.97%-$16.43M
Novo Nordisk A/SADR(NVO)63,81167,257+3,446$9.11M$8.01M1.92%-$1.10M
Korro Bio, Inc.(KRRO)71,42864,014-7,414$2.42M$2.14M0.51%-$279.9K
Femasys Inc30,60630,6060$34.9K$34.0K0.01%-$918
Alnylam Pharmaceuticals, Inc.(ALNY)45,0000-45,000$10.94M$0—-$10.94M
Amgen Inc.(AMGN)82,2710-82,271$25.71M$0—-$25.71M
Ascendis Pharma A/SADR(ASND)227,7620-227,762$31.06M$0—-$31.06M
Avadel Pharmaceuticals PlcADR1,189,5180-1,189,518$16.72M$0—-$16.72M
Ocular Therapeutix, Inc.(OCUL)514,6420-514,642$3.52M$0—-$3.52M
Praxis Precision Medicines, Inc.(PRAX)75,3190-75,319$3.12M$0—-$3.12M
Regeneron Pharmaceuticals, Inc.(REGN)17,5160-17,516$18.41M$0—-$18.41M
Xenon Pharmaceuticals Inc.(XENE)101,9590-101,959$3.98M$0—-$3.98M
Page 1 of 1
Tri Locum Partners LP — 13F Holdings — Q3 2024 | TickerTrail